Real-World Safety and Efficacy Clinical Data of an Improved Allergen-Specific Immunotherapy Product for the Treatment of Bee Venom Allergy.

The aim of this study is to explore the safety and efficacy of bee venom immunotherapy without HSA, in real-life patients. Methods: This is an observational retrospective study developed in seven hospitals in Spain, where patients treated with this immunotherapy were included. They gathered the protocol used to initiate the immunotherapy, adverse reactions, field re-stings, and the patient clinical data (clinical history, biomarkers, and skin prick test).

Fungi Sensitization in Spain: Importance of the Species and Its Major Allergen Alt a 1 in the Allergenicity.

Prevalence of allergy to fungi is around 3-10%. The most prevalent species involved in sensitizations are and . Our main objective was to estimate the prevalence of fungal sensitization and its variation across Spain.